March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc - Ortho-McNeil-Janssen - Document - PDFSEARCH.IO

First Page	Meta Content
	March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc Add to Reading List Document Date: 2011-03-04 17:07:37 Open Document File Size: 216,00 KB Share Result on Facebook City Titusville / / Company Ortho-McNeil-Janssen Pharmaceuticals Inc. / / IndustryTerm Healthcare professionals / healthcare providers / / MedicalCondition schizophrenia / infectious diseases / epilepsy / central nervous system disorders / / Organization FDA / Food and Drug Administration / / / Product topiramate / TOPAMAX / / ProvinceOrState New Jersey / / URL http / SocialTag Anticonvulsants Topiramate Treatment of bipolar disorder Pharmacology Ortho-McNeil-Janssen Ortho-McNeil Pharmaceutical Food and Drug Administration Pregnancy Johnson & Johnson Medicine

March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-McAdd to Reading List